Pfizer Announces Positive Phase 3 Top-line Results for Once-Weekly Investigational Long-Acting Human Growth Hormone to Treat Children with Growth Hormone Deficiency Oct 8, 2020
OPKO Health's BioReference Laboratories Announces New York City Schools COVID-19 Testing Program Sep 2, 2020
OPKO Health's BioReference Laboratories Launches Best-in-Class Next-Generation Sequencing (NGS) Assay Sep 1, 2020
OPKO Health’s GeneDx Enters into Agreement with Pediatrix Medical Group to Offer Neonatal Genomic Services Aug 12, 2020
OPKO Health's BioReference Laboratories Awarded Commercial Surge Capacity Testing for COVID-19 Emergency Response Contract by Centers for Disease Control and Prevention (CDC) Jul 20, 2020
